BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11153 related articles for article (PubMed ID: 12952283)

  • 1. MART-1 adenovirus-transduced dendritic cell immunization in a murine model of metastatic central nervous system tumor.
    Broder H; Anderson A; Kremen TJ; Odesa SK; Liau LM
    J Neurooncol; 2003; 64(1-2):21-30. PubMed ID: 12952283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant adenovirus-transduced dendritic cell immunization in a murine model of central nervous system tumor.
    Broder H; Anderson A; Odesa SK; Kremen TJ; Liau LM
    Neurosurg Focus; 2000 Dec; 9(6):e6. PubMed ID: 16817689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
    Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
    J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells.
    Ribas A; Butterfield LH; McBride WH; Jilani SM; Bui LA; Vollmer CM; Lau R; Dissette VB; Hu B; Chen AY; Glaspy JA; Economou JS
    Cancer Res; 1997 Jul; 57(14):2865-9. PubMed ID: 9230191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells.
    Ribas A; Butterfield LH; Hu B; Dissette VB; Chen AY; Koh A; Amarnani SN; Glaspy JA; McBride WH; Economou JS
    J Immunother; 2000 Jan; 23(1):59-66. PubMed ID: 10687138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.
    Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A
    Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
    Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
    J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells.
    Wan Y; Emtage P; Zhu Q; Foley R; Pilon A; Roberts B; Gauldie J
    Cell Immunol; 1999 Dec; 198(2):131-8. PubMed ID: 10648127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma.
    Xie J; Xiong L; Tao X; Li X; Su Y; Hou X; Shi H
    Lung Cancer; 2010 Jun; 68(3):338-45. PubMed ID: 19671483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells.
    Liao YP; Wang CC; Butterfield LH; Economou JS; Ribas A; Meng WS; Iwamoto KS; McBride WH
    J Immunol; 2004 Aug; 173(4):2462-9. PubMed ID: 15294960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.
    Zhai Y; Yang JC; Kawakami Y; Spiess P; Wadsworth SC; Cardoza LM; Couture LA; Smith AE; Rosenberg SA
    J Immunol; 1996 Jan; 156(2):700-10. PubMed ID: 8543823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-A2.1/K(b) transgenic murine dendritic cells transduced with an adenovirus encoding human gp100 process the same A2.1-restricted peptide epitopes as human antigen-presenting cells and elicit A2.1-restricted peptide-specific CTL.
    Yang S; Linette GP; Longerich S; Roberts BL; Haluska FG
    Cell Immunol; 2000 Aug; 204(1):29-37. PubMed ID: 11006015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma.
    Butterfield LH; Comin-Anduix B; Vujanovic L; Lee Y; Dissette VB; Yang JQ; Vu HT; Seja E; Oseguera DK; Potter DM; Glaspy JA; Economou JS; Ribas A
    J Immunother; 2008 Apr; 31(3):294-309. PubMed ID: 18317358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.
    Ribas A; Butterfield LH; Amarnani SN; Dissette VB; Kim D; Meng WS; Miranda GA; Wang HJ; McBride WH; Glaspy JA; Economou JS
    Cancer Res; 2001 Dec; 61(24):8787-93. PubMed ID: 11751400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells.
    Mehrotra S; Chhabra A; Chakraborty A; Chattopadhyay S; Slowik M; Stevens R; Zengou R; Mathias C; Butterfield LH; Dorsky DI; Economou JS; Mukherji B; Chakraborty NG
    Immunology; 2004 Dec; 113(4):472-81. PubMed ID: 15554925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus.
    Butterfield LH; Jilani SM; Chakraborty NG; Bui LA; Ribas A; Dissette VB; Lau R; Gamradt SC; Glaspy JA; McBride WH; Mukherji B; Economou JS
    J Immunol; 1998 Nov; 161(10):5607-13. PubMed ID: 9820539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.
    Song W; Kong HL; Carpenter H; Torii H; Granstein R; Rafii S; Moore MA; Crystal RG
    J Exp Med; 1997 Oct; 186(8):1247-56. PubMed ID: 9334364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors.
    Kikuchi T; Moore MA; Crystal RG
    Blood; 2000 Jul; 96(1):91-9. PubMed ID: 10891436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunization with dendritic cells infected with mTERT adenovirus vector effectively elicits immunity against mouse H22 hepatoma in vivo].
    Jiang N; Wang GS; Li H; Zhang J; Zhang JF; Yi SH; Yi HM; Yang Y; Cai CJ; Lu MQ; Chen GH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):405-9. PubMed ID: 19950546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 558.